Regional Editor

Lianxin Liu
The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
HomePage
Research Interests
hepatocellular carcinoma, cholangiocarcinoma, larproscopic liver resection, immunotherapy, checkpoint inhibitor, gallbladder cancer
Contributions:

Introduction of Chinese expert consensus on neoadjuvant therapy for primary liver cancer (2023 edition)

Mini-invasive Surgery
ISSN 2574-1225 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/